Personalised Adaptive Medicine (PERAMEDIC)

Qi, Sheng (Principal Investigator)

Status	Active
Effective start/end date	1/02/24 → 31/01/27

Funding

Horizon Europe: £598,695.89

1 Editorial

Can we create customized polypills for personalized drug formulation?
Qi, S., Jul 2025, In: Expert Opinion on Drug Safety. 22, 7, p. 915-918 4 p.
Research output: Contribution to journal › Editorial › peer-review

1 Citation (Scopus)